Airway ShieldTM

The world´s first device for endotracheal intubation that protects clinicians while facilitating the procedure.

Effective barrier for aerosols and droplets, reduces infection risk.
Disruptive concept, smart design, revolutionary technology.

Know more

Endotracheal Intubation: An Aerosol Generating Procedure

ETI is a complex and high-risk procedure. Only performed by highly trained clinicians. More than 50 million intubations are performed worldwide per year. It is the third most common procedure in US hospitals.

ETI permits mechanical ventilation in patients with severe respiratory failure, in the context of COVID-19 or other cause. It is also required in most surgeries.

It is an aerosol generating procedure (AGP) with high risk of infection for the operators. At present, clinicians represent 5.46 % of total COVID-19 cases in Spain, with a total of more than 79,000 cases.

The current COVID-19 pandemic has compelled the medical community worldwide to search for a device that could make ETI safer, both for patients and for clinicians. In this context, the Airway ShieldTM is a groundbreaking solution: a unique, disposable device that makes intubation safer for both patient and clinical staff, is easy to operate with minimal training, and is highly cost-effective.

Global airway management market value is 1.6 billion € per year.

The Airway ShieldTM

An innovative low-cost and safe solution for minimizing risks of ETI procedure.

Home
Seal to allow laryngoscope blade and endotracheal tube to pass, while minimizing aerosols and droplets leakage
The ‘Shield’ covers the patient’s mouth and protects the operator from infection
Seal to allow aspiration of secretions and/or aerosols
The ‘Airway’ facilitates intubation by guiding the endotracheal tube towards the larynx

The COVID-19 pandemic has raised an urgent need for adequate protective measures during high-risk aerosol-generating procedures such as endotracheal intubation (ETI).

Current clinical guidelines for airway management encourage clinicians to focus on using appropriate contact and airborne precautions.

The Airway ShieldTM is a cost-effective and revolutionary barrier device that protects medical staff during intubation procedures.

How it works

The simple yet innovative operating mechanism behind the Airway ShieldTM consists in supporting the tongue while creating a pathway for the endotracheal tube (ETT), so it can easily follow the direction set by the laryngoscope blade towards the larynx.

Home
1

Placing the Airway ShieldTM

Carefully following the palate, the device is introduced into the mouth until the shield is covering the mouth of the patient. The shield protects the operators from droplets and aerosols.

Home
2

Intubation

Like in a standard intubation, the video-laryngoscope is introduced first to obtain the view of the larynx, and then the ETT is introduced. The pathway of the device facilitates the introduction of the ETT following the blade of the laryngoscope towards the larynx.

Home
3

Removing the Airway ShieldTM

Once the ETT is in place and the ventilator is connected, the Airway ShieldTM is peeled away from the midline and removed. The exposure to aerosols and droplets has been minimized.

The benefits

The Airway ShieldTM is a cost-effective, safe, and innovative solution for avoiding clinician exposure to aerosols and droplets during airway management.

Patient Safety

Facilitates intubation, making the procedure safer.

Operator Protection

Protects clinicians from the risk of infection.

Reduce Aerosols and Droplets

Reduces exposure for all involved in the procedure.

Easy to use

Minimal training required.

 Portable

Available and ready to use in any circumstance.

Low-cost

Simple solution to a complex problem.

Disruptive technology

Revolutionary yet simple design.

Patented

Design and method protected by an international patent.

Testimonials

What the experts have to say about our device

I am excited to see such innovation in an area that has seen little change for many years. Like many great ideas, the concept is simple and makes one wonder why hasn’t this been done before.

Matthew DanAnaesthesiologist

I have been a doctor in Intensive Care Medicine for 8 years and I believe that this innovative new medical device could change the way we approach this difficult medical procedure worldwide.

Arina KeysSpecialist in Critical Care

Such a simple device and so well thought out. It not only acts as a barrier but also makes this critical procedure much easier.

Alberto BlancoSpecialist in Emergency Medicine

Meet the team

Dr. Julio Alonso

Founder and CEO

Joanne Zuo

Business Development

Eduardo Gutierrez

Product Manager

Silvia Chan

Digital Marketing Manager

Cambell Smyth

Industrial Designer

Dr. Bernadette Pfang

Medical Research & Communication

Timeline

Our product roadmap with milestones from the conceptualization phase in April-May 2020 to our commercial launch in March-April 2021.

IDEA

May 2020

First 3D Printing Prototypes

June 2020

International Patent Filed (PCT)

July 2020

Preclinical Studies Completed (Phase I and II)

August 2020

Initial Contacts with Manufacturers

September 2020

Design Optimization

October 2020

Initial Distributors Selection

November 2020

First Injection Molding Tool Contracted

December 2020

Pre-Production Samples for Testing / Private Funding Round

January 2021

Crowdfunding Campaign

February 2021

CE Mark Achieved / First Study in Humans

March 2021

First Batch of Commercial Units Sent to Distributors

COMMERCIAL LAUNCH

Get in touch

Spain

Calle Moctezuma 3, Santander.
39003 Cantabria. Spain
+34 640 907 955
info@airwayshield.com

Newsletter

Subscribe to our product newsletter for insights about our progress and airway management issues